Using MRI to Understand Prostate Uptake in PET Scans
Author Information
Author(s): Şam Özdemir Merve, Kaya Nurullah, Savun Metin, Keskin Emin Taha, Yüzkan Sabahattin, Arslan Fatma Zeynep, Budak Burcu, Omak Özgür, Yardımcı Aytül Hande, Özdemir Harun
Primary Institution: Başaksehir Çam and Sakura City Hospital, Istanbul, Turkey
Hypothesis
Can multi-parametric MRI (mpMRI) effectively characterize incidental prostate uptake observed in 18F-FDG PET/CT scans?
Conclusion
The study found that high PSA density values, PI-RADS scores, and PSA levels are more predictive of malignancy than PET-CT findings.
Supporting Evidence
- 70.6% of cases showed no correlation between PET/CT uptake and mp-MRI findings.
- Among patients with PI-RADS 3-4-5 scores, there was a correlation with malignancy.
- Biopsies revealed 56.7% of cases were malignant.
- PI-RADS score groups were independent risk factors for predicting malignancy.
Takeaway
Doctors used special MRI scans to see if areas in the prostate that lit up in a PET scan were cancerous, and they found that certain blood test results were better at predicting cancer.
Methodology
The study involved 92 patients who underwent both mpMRI and 18F-FDG PET/CT scans, with biopsies performed on 30 patients to confirm findings.
Potential Biases
Potential bias due to the retrospective nature and selection of patients who had undergone both imaging methods.
Limitations
The study was retrospective and included a limited number of patients with both imaging and biopsy results.
Participant Demographics
Median age of participants was 66 years, with a PSA median of 3.6 ng/ml.
Statistical Information
P-Value
p<0.05
Confidence Interval
0.01−0.26
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website